Pre- and post-analytical factors that may influence use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer

被引:37
|
作者
Price, CP
Allard, J
Davies, G
Dawnay, A
Duffy, MJ
France, M
Mandarino, G
Ward, AM
Patel, B
Sibley, P
Sturgeon, C
机构
[1] St Bartholomews & Royal London Sch Med & Dent, Dept Clin Biochem, London E1 2AD, England
[2] Bayer Grp Diagnost, Tarrytown, NY 10591 USA
[3] Wrexham Maelor Hosp, Dept Biochem Med, Wrexham LL13 7TD, Clwyd, Wales
[4] Barts & London NHS Trust, Dept Clin Biochem, London EC1A 7BE, England
[5] St Vincents Hosp, Dept Nucl Med, Dublin 4, Ireland
[6] Manchester Royal Infirm, Dept Chem Pathol, Manchester M13 9WL, Lancs, England
[7] Abbott Labs, Abbott Pk, IL 60064 USA
[8] No Gen Hosp NHS Trust, Dept Immunol, Sheffield S5 7YT, S Yorkshire, England
[9] Euro DPC Ltd, Llanberis LL55 4EL, Caerns, Wales
[10] Royal Infirm, Dept Clin Biochem, Edinburgh EH3 9YW, Midlothian, Scotland
关键词
D O I
10.1258/0004563011900632
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
[No abstract available]
引用
收藏
页码:188 / 216
页数:29
相关论文
共 50 条
  • [41] Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians
    Austin, OJ
    Valente, S
    Hasse, LA
    Kues, JR
    ARCHIVES OF FAMILY MEDICINE, 1997, 6 (05) : 453 - 458
  • [42] Body Mass Index Adjusted Prostate-specific Antigen and Its Application for Prostate Cancer Screening
    Liang, Yuanyuan
    Ankerst, Donna P.
    Sanchez, Michael
    Leach, Robin J.
    Thompson, Ian M.
    UROLOGY, 2010, 76 (05) : 1268.e1 - 1268.e6
  • [43] Utility of free prostate specific antigen serum level and its related parameters in the diagnosis of prostate cancer
    Haroun, Azmi A.
    Hadidy, Azmy S.
    Awwad, Ziad M.
    Nimri, Caramella F.
    Mahafza, Waleed S.
    Tarawneh, Emad S.
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2011, 22 (02) : 291 - 297
  • [44] Limitations in the use of serum prostate specific antigen levels to monitor patients after treatment for prostate cancer
    Vicini, FA
    Vargas, C
    Abner, A
    Kestin, L
    Horwitz, E
    Martinez, A
    JOURNAL OF UROLOGY, 2005, 173 (05): : 1456 - 1462
  • [45] EVALUATION OF PERCENTAGE OF FREE SERUM PROSTATE-SPECIFIC ANTIGEN TO IMPROVE SPECIFICITY OF PROSTATE-CANCER SCREENING
    CATALONA, WJ
    SMITH, DS
    WOLFERT, RL
    WANG, TJ
    RITTENHOUSE, HG
    RATLIFF, TL
    NADLER, RB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (15): : 1214 - 1220
  • [46] Percentage of free serum prostate-specific antigen as a predictor of pathologic features of prostate cancer in a screening population
    Arcangeli, CG
    Humphrey, PA
    Smith, DS
    Harmon, TJ
    Shepherd, DL
    Keetch, DW
    Catalona, WJ
    UROLOGY, 1998, 51 (04) : 558 - 564
  • [47] Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran
    Hosseini, Seyyed Yousof
    Moharramzadeh, Massood
    Ghadian, Ali Reza
    Hooshyar, Hassan
    Lashay, Ali Reza
    Safarinejad, Mohammah Reza
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (05) : 406 - 411
  • [48] Serum-to-urinary prostate specific antigen ratio: Its impact in distinguishing prostate cancer when serum prostate specific antigen level is 4 to 10 NG/ML.
    Irani, J
    Millet, C
    Levillain, P
    Dore, B
    Begon, F
    Aubert, J
    JOURNAL OF UROLOGY, 1997, 157 (01): : 185 - 188
  • [49] Is pre-biopsy serum prostate specific antigen retesting always justified? A study of the influence of individual and analytical factors on decision making for biopsy referral
    Ferraro, Simona
    Bussetti, Marco
    Rossi, Roberta Simona
    Incarbone, Giacomo Piero
    Panteghini, Mauro
    CLINICA CHIMICA ACTA, 2021, 516 : 77 - 82
  • [50] Serum prostate specific antigen testing may predict extracapsular extension and tumor grading in patients with prostate cancer.
    Barberis, MC
    Dolci, A
    Alexiadis, S
    Lucchi, P
    Bellati, P
    CLINICAL CHEMISTRY, 2004, 50 (06) : A80 - A80